Device Trial Radar · NCT03611504
Hemospray in Gastrointestinal Bleeding: A Real-life Multicenter Cohort
Last checked: Nov 20, 2026Latest source record: Feb 21, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
261
Actual
Start
Jul 1, 2018
Primary completion
Dec 30, 2018
Study completion Dec 30, 2018
Sponsor
- Lead sponsor
- Hospital Universitario Ramon y CajalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Salamanca; Hospital del Mar; Puerta de Hierro University Hospital; Complejo Hospitalario de Navarra; Hospital de Henares; Fundación de Investigación Biomédica - Hospital Universitario de La Princesa; Quirón Madrid University Hospital; Hospital de Cruces; Hospital General Universitario Gregorio Marañon; Hospital Universitario Central de Asturias; Hospital Universitario de Cabuenes; Hospital Universitario Doctor Peset; Hospital del Rio Hortega; Hospital Universitario Madrid Sanchinarro; Hospital de Aviles; Hospital IMQ Zorrozaurre
- First posted
- Aug 2, 2018
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an observational, retrospective, analytical, and multicenter study conducted at 17 hospitals. Our research aims to assess the effectiveness of Hemospray® in patients with gastrointestinal bleeding in clinical practice. Besides, we aim to detect predictors of treatment failure defined as unsuccessful immediate hemostasis or rebleeding.
Conditions
- Gastrointestinal Hemorrhage
- Ulcer Hemorrhage
- Tumor Bleeding
Interventions
Hemospray®Device
Hemospray® application
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hemospray® intraprocedural bleeding controlTime frame: From Hemospray® first application up to the end of the endoscopic procedure. This variable should be assessed in day 1.
- Rebleeding rateTime frame: Date of Hemospray® application until rebleeding, assessed up to 48 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital Universitario Ramón y Cajal
Madrid, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.